Skip to main content
. 2017 Oct 26;8(62):105196–105210. doi: 10.18632/oncotarget.22111

Figure 3. Higher risk and lower survival probability of patients with lung cancer according to lower mRNA levels of the catalytic subunits of PP1.

Figure 3

(A and C) Risk of worse survival probability according to mRNA levels in patients with adenocarcinoma (left, A) or squamous cell carcinoma (right, C). (B and D) Survival probability (log rank) of patients with lung cancer according to the mRNA levels of the joint catalytic subunits of PP1. Values were taken above or below the average for each subunit evaluated. High or low risks were taken according to the values of figure (A) and (C). (B) Lung adenocarcinoma; (D) Squamous cell carcinoma. The TCGA cohort was used.